Emilia Vitale

Prof. Emilia Vitale

CNR
+1
orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1991 in Nature
Verified
Journal Article
Closed access
BLBrendan Lee
Brendan Lee
MGMaurice Godfrey
Maurice Godfrey
Emilia VitaleEmilia Vitale
Emilia Vitale
HHHisae Hori
Hisae Hori
MAMarie-Genevi
Marie-Genevi
PTPetros Tsipouras
Petros Tsipouras

1 December 1993 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
KPK. Petrukhin
K. Petrukhin
SFS. G. Fischer
S. G. Fischer
MPM. Pirastu
M. Pirastu
RTR.E. Tanzi
R.E. Tanzi
ICIgor P Chernov
Igor P Chernov
TGT.C. Gilliam
T.C. Gilliam

2 April 1992 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
PTPetros Tsipouras
Petros Tsipouras
RMRichard Del Mastro
Richard Del Mastro
MSMansoor Sarfarazi
Mansoor Sarfarazi
BLBrendan Lee
Brendan Lee
Emilia VitaleEmilia Vitale
Emilia Vitale
TSthe International Marfan Syndrome Collaborative Study*
the International Marfan Syndrome Collaborative Study*
The large glycoprotein fibrillin is a structural component of elastin-containing microfibrils found in many tissues. The Marfan syndrome has been linked to the fibrillin gene on chromosome 15, but congenital contractural arachnodactyly, which shares some of the physical features of the syndrome, has been linked to the fibrillin gene on chromosome 5.

12 December 2018 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
PIPaola Italiani
Paola Italiani
PPPuxeddu Puxeddu
Puxeddu Puxeddu
SNSabrina Napoletano
Sabrina Napoletano
ESEmanuele Scala
Emanuele Scala
DMDaniela Melillo
Daniela Melillo
ACAlfonso Di Costanzo
Alfonso Di Costanzo
Although the mechanisms underlying AD neurodegeneration are not fully understood, it is now recognised that inflammation could play a crucial role in the initiation and progression of AD neurodegeneration. A neuro-inflammatory network, based on the anomalous activation of microglial cells, includes the production of a number of inflammatory cytokines both locally and systemically. These may serve as diagnostic markers or therapeutic targets for AD neurodegeneration. We have measured the levels of the inflammation-related cytokines and receptors of the IL-1 family in serum of subjects with AD, compared to mild cognitive impairment (MCI), subjective memory complaints (SMC), and normal healthy subjects (NHS). Using a custom-made multiplex ELISA array, we examined ten factors of the IL-1 family, the inflammation-related cytokines IL-1α, IL-1β, IL-18, and IL-33, the natural inhibitors IL-1Ra and IL-18BP, and the soluble receptors sIL-1R1, sIL-1R2, sIL-1R3, and sIL-1R4. The inflammatory cytokines IL-1α and IL-1β, their antagonist IL-1Ra, and their soluble receptor sIL-1R1 were increased in AD. The decoy IL-1 receptor sIL-1R2 was only increased in MCI. IL-33 and its soluble receptor sIL-1R4 were also significantly higher in AD. The soluble form of the accessory receptor for both IL-1 and IL-33 receptor complexes, sIL-1R3, was increased in SMC and even more in AD. Total IL-18 levels were unchanged, whereas the inhibitor IL-18BP was significantly reduced in MCI and SMC, and highly increased in AD. The levels of free IL-18 were significantly higher in MCI. AD is characterised by a significant alteration in the circulating levels of the cytokines and receptors of the IL-1 family. The elevation of sIL-1R4 in AD is in agreement with findings in other diseases and can be considered a marker of ongoing inflammation. Increased levels of IL-1Ra, sIL-1R1, sIL-1R4, and IL-18BP distinguished AD from MCI and SMC, and from other inflammatory diseases. Importantly, sIL-1R1, sIL-1R3, sIL-1R4, and IL-18BP negatively correlated with cognitive impairment. A significant elevation of circulating sIL-1R2 and free IL-18, not present in SMC, is characteristic of MCI and disappears in AD, making them additional interesting markers for evaluating progression from MCI to AD.

30 November 1991 in Developmental Biology
Verified
Journal Article
Closed access
HSHiroaki R. Suzuki
Hiroaki R. Suzuki
BPBabu J. Padanilam
Babu J. Padanilam
Emilia VitaleEmilia Vitale
Emilia Vitale
FRFrancesco Ramirez
Francesco Ramirez
MSMichael Solursh
Michael Solursh

15 May 1992 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
WHW A Horton
W A Horton
MMM A Machado
M A Machado
JEJ Ellard
J Ellard
DCD Campbell
D Campbell
JBJ Bartley
J Bartley
BLB Lee
B Lee
A subtle mutation in the type II collagen gene COL2A1 was detected in a case of human hypochondrogenesis by using a chondrocyte culture system and PCR-cDNA scanning analysis. Chondrocytes obtained from cartilage biopsies were dedifferentiated and expanded in monolayer culture and then redifferentiated by culture over agarose. Single-strand conformation polymorphism and direct sequencing analysis identified a G----A transition, resulting in a glycine substitution at amino acid 574 of the pro alpha 1(II) collagen triple-helical domain. Morphologic assessment of cartilage-like structures produced in culture and electrophoretic analysis of collagens synthesized by the cultured chondrocytes suggested that the glycine substitution interferes with conversion of type II procollagen to collagen, impairs intracellular transport and secretion of the molecule, and disrupts collagen fibril assembly. This experimental approach has broad implications for the investigation of human chondrodysplasias as well as human chondrocyte biology.